Prabhudas Lilladher's joint MD Dilip Bhat is positive on Infy, Wipro and Tech Mahindra. He feels at the moment market valuations are not cheap and there won't be any runaway rally in the market.
In a statement, Ranbaxy said that its New Jersey-based Ohm Labs has received an Establishment Inspection Report (EIR) from the US drug regulator for its December 2012 inspection.
Drug maker Ranbaxy received a clean chit from the US Food and Drug Administration (USFDA) for its New-Jersey based Ohm Laboratories.
Pathik Gandotra of Dron Capital feels Ranbaxy Labs can also give a very high return, but it is extremely risky, he adds.
Today, the pharma major Ranbaxy has surged 8.2% on US FDA (Food and Drug Administration) approval for Generic Lipitor. The drug will be manufactured by Ohm Laboratories, reports CNBC-TV18.